Immunology of the antiphospholipid antibody syndrome.
Immunology of the antiphospholipid antibody syndrome.
复制标题
抗磷脂抗体综合征的免疫学。
DOI:
10.1002/art.1780390903
复制
发表时间:
1996
影响因子:
--
通讯作者:
Roubey,RA
中科院分区:
文献类型:
--
作者:
Roubey,RA
Like the femme fatale in The Beatles’ Rocky Raccoon, antiphospholipid antibodies (aPL) and the syndrome with which they are associated (thrombosis, recurrent fetal deaths, thrombocytopenia) have attracted considerable attention despite a serious nomenclature problem. Along with increasing experience in the optimal management of patients with the aPL syndrome and growing evidence that autoantibodies may play a direct pathophysiologic role, research over the past several years demonstrates that a large proportion of “antiphospholipid” autoantibodies do not, in fact, recognize phospholipids. These new data indicate that the antigenic targets of antibodies detected in conventional anticardiolipin and lupus anticoagulant assays are phospholipid-binding plasma proteins, most notably, &-glycoprotein I (&GPI) and prothrombin or complexes of these proteins with phospholipids. Further, autoantibodies to other phospholipid-binding plasma proteins and certain molecules expressed on vascular endothelium may also be associated with the antiphospholipid antibody syndrome (APS) although they are not detectable in standard aPL assays. This review summarizes recent information on the specificities of autoantibodies associated with APS and discusses the insights these data offer into the potential role of autoantibodies in the syndrome’s pathophysiology.